Core Insights - Shanghai Pudong Development Bank (SPDB) has launched a "private investment" guarantee business, aligning with the "early and small loans" strategy to support the real economy [1][2] - The initiative is part of the implementation of a special guarantee plan for private investment, aimed at addressing the funding challenges faced by early and mid-stage innovative enterprises, particularly in the biopharmaceutical sector [1] Group 1 - SPDB has tailored a financing solution for Hejing Pharmaceutical, a new drug development company, which has received FDA's Investigational New Drug (IND) approval for its next-generation product targeting non-small cell lung cancer [2] - The bank provided a credit limit of 10 million yuan to Hejing Pharmaceutical, facilitating the first batch of "private investment" guarantee loans in the city before the Spring Festival, thereby alleviating the company's financing pressure [2] - The focus of SPDB's "private investment" guarantee business is on the financing needs of small and micro enterprises, utilizing an innovative bank-guarantee cooperation model to offer low-cost and efficient financing support [2] Group 2 - SPDB plans to enhance support for early and mid-stage enterprises in key sectors such as technology innovation, manufacturing, and small businesses, aiming to activate private investment and contribute to high-quality economic development in Shanghai [2]